Löffler, Maximilian T. http://orcid.org/0000-0002-6022-3682
Ngarmsrikam, Chotigar
Giesler, Paula
Joseph, Gabby B.
Akkaya, Zehra
Lynch, John A.
Lane, Nancy E.
Nevitt, Michael
McCulloch, Charles E.
Link, Thomas M.
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01-AR064771, R01-AR078917, and R01-AG070647, R01-AR064771, R01-AR078917, and R01-AG070647, R01-AR064771, R01-AR078917, and R01-AG070647, R01-AR064771, R01-AR078917, and R01-AG070647, R01-AR064771, R01-AR078917, and R01-AG070647, R01-AR064771, R01-AR078917, and R01-AG070647)
Article History
Received: 24 January 2024
Accepted: 29 March 2024
First Online: 17 April 2024
Declarations
:
: The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at the National Institutes of Health (NIH) appointed an independent Observational Study Monitoring Board (OSMB) to oversee the OAI study from 2002 to 2014. The OSMB’s responsibilities included protecting the safety of study participants, considering ethical and other external factors that could impact participant safety, and monitoring the progress of the study. This Health Insurance Portability and Accountability Act (HIPAA)-compliant study has been approved by the OSMB and written informed consent was obtained from all study participants. The OSMB was disbanded upon study completion.
: Not applicable.
: The authors declare no competing interests.